A Phase 2 Study of Neoadjuvant Docetaxel, Oxaliplatin, S-1 in Patients With Unresectable Locally Advanced or Distant Metastasis Limited to Lymph Node Gastric Cancer
Clinical trial NCT05184803 · RECRUITING
Trial details
- NCT number
- NCT05184803
- Sponsor
- Asan Medical Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-23
- Primary completion
- 2027-06-30
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.